https://www.optimumcomms.com/wp-content/uploads/2026/10/ionctura-website-logo.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-11-06 14:07:352026-11-06 14:07:57Combinations of iOnctura’s roginolisib revert immune suppression in immunotherapy-resistant NSCLC
https://www.optimumcomms.com/wp-content/uploads/2026/10/ionctura-website-logo.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-11-06 14:07:352026-11-06 14:07:57Combinations of iOnctura’s roginolisib revert immune suppression in immunotherapy-resistant NSCLC
https://www.optimumcomms.com/wp-content/uploads/2024/05/Template_Logo_300x180px-80x80Web_Logos-1.jpg
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-11-05 15:00:452026-11-05 15:00:45Resolution Therapeutics Announces Positive Interim Phase I/II EMERALD Data for Regenerative Macrophage Therapy RTX001 in End-Stage Liver Disease
https://www.optimumcomms.com/wp-content/uploads/2025/09/Hansa-Biopharma.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-11-05 12:46:292026-11-05 12:46:29Hansa Biopharma presenting at Stifel 2026 Healthcare Conference
https://www.optimumcomms.com/wp-content/uploads/2026/02/Link-Biologics_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-11-05 08:33:132026-11-05 08:33:13Link Biologics completes IND-enabling preclinical programme for LB001, a first-in-class novel therapy for dry eye disease
https://www.optimumcomms.com/wp-content/uploads/2026/04/asgard-logo-for-website.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-11-04 16:07:282026-11-04 16:07:28Asgard Therapeutics announces publication in Immunity demonstrating induction of cancer-fighting tertiary lymphoid structures across seven tumor types – and will present new AT-108 biomarker data at SITC 2026
https://www.optimumcomms.com/wp-content/uploads/2026/07/AC-Immune-website-logo.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-11-04 12:02:512026-11-04 12:02:51AC Immune Third Quarter 2026 Financial and Corporate Update
https://www.optimumcomms.com/wp-content/uploads/2025/09/Hansa-Biopharma.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-11-04 09:52:142026-11-04 09:52:14Hansa Biopharma to participate in BIO-Europe 2026
https://www.optimumcomms.com/wp-content/uploads/2026/06/Novo-Nordisk-Foundation-website-logo-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-11-03 08:30:442026-11-03 16:00:22New research initiative will utilise AI to optimise Nordic energy grid capacity, improve resilience and prepare for future needs
https://www.optimumcomms.com/wp-content/uploads/2023/02/Sofinnova_Logo_300-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-11-02 08:18:082026-11-02 08:18:08Sofinnova Partners promotes Javier Nunez-Vicandi to Partner, strengthening its Digital Medicine strategy
https://www.optimumcomms.com/wp-content/uploads/2025/09/Hansa-Biopharma.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-30 16:43:472026-10-30 16:43:47Hansa Biopharma to participate in the BioStock Life Science Summit
https://www.optimumcomms.com/wp-content/uploads/2026/10/iOnctura_logo_FINAL_Black.png
359
1920
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-29 13:03:312026-10-29 13:03:31iOnctura to present late-breaking data on roginolisib in immunotherapy-resistant NSCLC at SITC
https://www.optimumcomms.com/wp-content/uploads/2026/10/GESYNTA-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-29 08:54:162026-10-29 08:54:16Exogenus Therapeutics leads a €13 million EU-funded consortium to advance a new secretome-based therapy for osteoarthritis
https://www.optimumcomms.com/wp-content/uploads/2026/07/simris-website-logo.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-29 08:31:442026-10-29 08:31:44Simris Group appoints experienced ADC clinical development leader Dr. András Strassz as Chief Medical Officer
https://www.optimumcomms.com/wp-content/uploads/2026/10/Template_Logo_300x180px-80x80Web_Logos-3.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-29 08:30:402026-10-29 08:30:40ALLOX closes $10.5M seed financing and appoints Morten Graugaard as Chair to scale allosteric drug discovery platform and build pipeline
https://www.optimumcomms.com/wp-content/uploads/2025/09/Hansa-Biopharma.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-28 11:57:212026-10-28 11:57:21Hansa Biopharma to host Q3 2026 interim results conference call
https://www.optimumcomms.com/wp-content/uploads/2025/12/Oncoinvent_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2026-10-28 08:30:332026-10-28 08:30:33Oncoinvent appoints Dr. Zuzana Jiráková Trnková as Chief Medical Officer to lead Phase 3 preparations for Radspherin®We’d love to hear from you
For more information about Optimum Strategic Communications, please get in touch.
